invest2 publishers
Novo Nordisk took equity in the buyer of the Parkinson's therapy it shelved
Cellular Intelligence has added Bob Langer and Yann LeCun to its scientific advisory board. The $62m to $70m it has raised now has to take STEM-PD, the cell therapy Novo Nordisk dropped, through Phase 2.
Reality
- Evidence45
- Adoption32
- Hype gap+38
- Incentives72
- Confidence58